For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.
Case Studies: Malpractice or Bad Outcome?
A Practical Protocol: Identifying Thyroidectomy Patients at Low Risk for Significant Hypocalcemia
Researchers from Johns Hopkins School of Medicine have identified a means of detecting thyroidectomy patients who can safely be discharged early after surgery, with little risk of developing significant hypocalcemia.
Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
Recurrent respiratory papillomatosis (RRP) remains a devastating disease for pediatric patients.
HPV-Oropharyngeal Cancer Link May Affect Cancer Screening and Prognosis: The link offers potential for improved detection and prevention, but more research is needed
Gene Therapy: A Promising Role in Otolaryngology
After a hiatus associated with a checkered past, gene therapy is again showing promise in several fields of medicine, and otolaryngology is no exception.
